Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder

PURPOSE: The activity and safety of neoadjuvant nivolumab plus gemcitabine/cisplatin (N+GC) were tested in patients with muscle-invasive bladder urothelial carcinoma (MIBC). MATERIALS AND METHODS: In a prospective phase II trial, patients with cT2-T4a N0 MIBC who were eligible for cisplatin and medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hongsik, Jeong, Byong Chang, Hong, Joohyun, Kwon, Ghee Young, Kim, Chan Kyo, Park, Won, Pyo, Hongryull, Song, Wan, Sung, Hyun Hwan, Hong, Jung Yong, Park, Se Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101782/
https://www.ncbi.nlm.nih.gov/pubmed/36228654
http://dx.doi.org/10.4143/crt.2022.343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101782/
https://www.ncbi.nlm.nih.gov/pubmed/36228654
http://dx.doi.org/10.4143/crt.2022.343

Ejemplares similares